INTRODUCTION
Migration and invasion are the principal mechanisms involved in cancer mortality, when cancer cells invade and migrate, a number of proteolytic enzymes contribute to the degradation of environmental barriers, such as the extracellular matrix (ECM) and basement membrane (1) . Matrix metalloproteinases (MMPs), a family of zinc-containing endopeptidases, are principal enzymes in extracellular matrix degradation, which are essential in the invasive growth, metastasis and angiogenesis of cancer (2) (3) (4) (5) (6) . In normal physiological conditions, the activities of MMPs are precisely regulated, but during pathological circumstances, especially malignant tumors, the activities of MMPs are deregulated and their expressions are often associated with poor prognosis (7, 8) . MMP-2 and -9, which are abundantly expressed in various malignant tumors, are considered to play critical roles in tumor invasion and metastasis (9) (10) (11) . Therefore compounds inhibiting the expressions and activities of MMPs, especially MMP-2 and -9, would have huge potentials in clinical applications.
Right now, more than 20,000 new compounds have been isolated from marine organisms; numbers of these naturally occurring derivatives are developed as potential candidates for pharmaceutical applications (12) . Phlorotannins are secondary metabolites distributed in a variety of plants. They are phloroglucin derivatives with a variety of biological functions in vitro and in vivo, such as antioxidant, anti-HIV, antitumor, and anti-inflammation (13) (14) (15) . 6,6'-bieckol ( Fig. 1 ) isolated from marine alga Ecklonia cava is a important derivative of phlor-http://bmbreports.org BMB reports oglucin which can inhibit the expressions of MMPs, however, 6,6'-bieckol hasn't been widely investigated (16, 17) . The focus of this study is to reveal that 6,6'-bieckol have inhibitions on the expressions of MMPs and check the influence of 6,6'-bieckol on the cell viability and cell behavior in HT1080 cell line. In addition, investigate the mechanisms of 6,6'-bieckol down-regulated MMPs expressions in HT1080 cell line.
RESULTS

Cell viability (MTT) assay
MTT assays were performed using HT1080 cell line to determine whether 6,6'-bieckol can have a toxic effect on HT1080 cell line. Fig. 2 shows a comparison of cell incubate for 48 h with various concentrations (0-250 μM) of 6,6'-bieckol. The values for all 6,6'-bieckol concentrations were similar to control (0 μM 6,6'-bieckol), indicating that cell viability was not affected at the concentrations range (0-200 μM).
In vitro effects of 6,6'-bieckol on the invasion and migration in HT1080 cell line
Initially, we measured the cytotoxicity of 6,6'-bieckol on HT1080 cell line by MTT assay. 6, 6 '-bieckol at the tested concentrations (0-200 μM). did not significantly cytotoxic, only at 200 μM concentration cells showed 96% cell viability. Therefore the cells were treated with 6,6'-bieckol in the concentration range 0-100 μM during subsequent experiments. To investigate whether 6,6'-bieckol inhibits tumor invasion and migration, Matrigel invasion and wound migration assays were performed in 6,6'-bieckoltreated HT1080 cells. Treatment with 0-100 μM 6,6'-bieckol reduced the invasiveness of cells induced by serum, while 100 μM 6,6'-bieckol significantly blocked tumor invasion (Fig. 3A) . In addition, 6,6'-bieckol suppressed the migration of HT1080 cells across the wounded space in a dose dependant manner (Fig. 3B ).
These results suggest that 6,6'-bieckol may be used for suppressing HT1080 cell metastasis and migration.
Effects of 6,6'-bieckol on the 3D culture in HT1080 cell line
The cells behavior and morphology in 3D culture system is quite different from that observed in the 2D system (18) . To in-http://bmbreports.org vestigate the effects of 6,6'-bieckol on HT1080 cell line, we seeded the cells with same density suspended into 3D collagen gel various 6,6'-bieckol final concentrations. After 48 h, the control (0 Mm 6,6'-bieckol) ( Fig. 3C ) stretched out in the gel and formed many branched and elongated structures in type I collagen matrix. In contrast, the branched structures of the cells treated with 5 μM concentration of 6,6'-bieckol was reduced, and when the concentration increased to 100 μM, the branched structure disappeared, and interestingly the cells change to a spherical shape. These results suggest that the 6,6'-bieckol influenced cell shape and morphology in 3D culture condition.
Effects of 6,6'-bieckol influenced the protein levels of MMP-2 and -9 on HT1080 cell line
To investigate whether 6,6'-bieckol can inhibit protein levels of MMP-2 and -9, gelatin zymography analysis was performed. As shown in Fig. 4A , protein expressions for MMP-2 and -9 were clearly inhibited in 6,6'-bieckol treated cells. Down-regulation of MMP-2 and -9 expressions by the treatment of 6,6'-bieckol was observed in a dose-dependent manner. Further as shown in Fig. 4B , from the Western blot studies, the MMP-2 and -9 proteins expression were inhibited by 6,6'-bieckol in a more or less similar manner with zymography analysis results. Meanwhile according to MTT cell viability assays, it was revealed that these concentrations were not cytotoxic, so these MMP-2,-9 inhibitions were not due to cytotoxic influence.
Effects of 6,6'-bieckol influenced AP-1 and NF-κB by their protein level expressions on HT1080 cell line
Western blot studies were carried out to assay the down-regulation of above protein expressions and figure out the possible mechanism for the effects of 6,6'-bieckol on expressions of activator protein-1 (AP-1) and nuclear factor-kappa B (NF-κB). As shown in Fig. 4C, 6 ,6'-bieckol did not exhibit a clear effect to inhibit AP-1(c-jun) expression. The NF-κB transcription family proteins consist of several protein subunits, therefore, expressions of NF-κB（p65 & p50） proteins were studied following treatment with 6,6'-bieckol. And it was clearly found that the level of NF-κB (p65&p50) was decreased in a dose-dependent manner.
DISCUSSION
6,6'-bieckol is a phloroglucinal derivative with a variety of biological functions in vitro and in vivo was discovered in our lab (19) . An imbalance between the inhibition and activation of MMPs relates to the pathology of diseases such as osteoarthritis, rheumatoid arthritis, tumor metastasis, cardiovascular disease and congestive heart failure (20) (21) (22) . In this study, we selected HT1080 cell line that is commonly used as a model for MMP studies to assess the effect of 6,6'-bieckol on MMP-2 and -9 expressions. 6,6'-bieckol with selected concentrations (0-200 μM) were treated to cultured HT1080 cells and MMP-2 and -9 expressions were induced with an extremely potent tumor promote (PMA) (23) . At the promoter site of MMP-2 and -9 genes, there are several putative binding sites for transcription factors that regulate gene expressions. This promoter contains an AP-1 binding consensus site at -79 upstream from the starter site and further upstream there is a cluster of regulatory elements including another AP-1 binding site, an AP-2 and NF-κB binding sites. It is commonly known that MMP-9 transcription regulates mainly via AP-1 (24, 25) . But under some inflammatory or other pathology conditions MMP-2 and -9 transcriptions can be regulated by NF-κB via different signaling pathways (26) . Interestingly, 6,6'-bieckol inhibited NF-κB gene expressions with a similar dose-dependent manner observed in MMP-2 and -9 gene expressions, however did not influence AP-1 expressions significantly. Because of the relations of NF-κB and AP-1 for the expressions of MMP-2 and -9 has not been clearly confirmed, it is hard to give a specific conclusion (27, 28) . These phenomena may be contributed by the 6,6'-bieckol unique chemical structure.
MMPIs entering clinical trial were synthetic in origin, and their undesirable side-effects led to failure of the trials (29), meanwhile discovering the ideal MMPIs from marine natural products is a very hot topic at present. In our continuous investigation of 6,6'-bieckol with a wide bioactive spectrum reported recently, the effects of on MMPs and cell morphology indicated that 6,6'-bieckol is possession of potential activities. The reasons should be discussed based on the structural features of the tested isolate-6,6'-bieckol The structure-activity relationship (SAR) could be described due to unique skeleton. First, the numbers of hydroxyl groups present in the chemical structure probably play an important role because of the higher polymerization of phloroglucinal units; second, the O-bridge linkages (ether linkage) among phloroglucinals donated more free anions to attract responsible receptors.
Summarizing the results of this study, it can be concluded that 6,6'-bieckol acts as an inhibitor of MMP-2 and -9 expressions by down-regulation of NF-κB. Further, it can be presumed that the inhibition of MMP-2 and -9 could be one of the mechanisms by suppression of 6,6'-bieckol on the migration and 3D culture of HT1080 cell line. Hence, it should be suggested that 6,6'-bieckol can be an effective candidate for application used as drug for the symptoms of cancer. 1 H NMR (400 MHz) and 13 C NMR (100 MHz) spectra were recorded on a JEOL JNM-ECP 400 NMR spectrometer (JEOL, Japan), using DMSO-d6 solvent peak (2.50 ppm in 1 H and 39.5 ppm in 13 C NMR) as an internal reference standard. For some signals, the chemical shifts approximated the third decimal place. This is to distinguish between signals of very close value but which could nevertheless be clearly differentiated by visual inspection of the spectra. MS spectra were obtained on a http://bmbreports.org BMB reports 
MATERIALS AND METHODS
General materials
Cell culture
HT1080 human fibrosarcoma cells which were from American Type Culture Collection (ATCC) were routinely grown in Dulbecco's modified Eagle's medium (Gibco) supplemented with 5% without heat-inactivated fetal bovine serum (Gibco), 100 U/ml penicillin, 100 mg/ml streptomycin, in 5% CO2 in air at 37 o C. For experiments, cells were passaged at least for 5 times and detached with Trypsin-EDTA.
Cell viability (MTT) assay
HT1080 cell line were seeded in 96-well plates at a density of 1 × 10 3 cells/well in 200 μl DMEM containing 10% fetal bovine serum. Twenty-four hours after seeding, removed the medium and the cells were incubated for 2 days with DMEM containing 1% FBS in the absence or presence of various concentrations of 6,6'-bieckol. Two days later, 100 μl of MTT (3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (0.5 mg/ml final concentration) solution was added to each well and incubator for another 4h at 37 o C in 5% CO2. Then absorbance was measured on a microplate reader (ELX800, Biotek, USA) at a test wavelength of 490 nm.
In vitro invasion assay
An in vitro invasion assay was performed using a 24-well transwell unit (8 μm pore size) with Polyvinylpyrrolidone-free polycarbonate (PVPF) filters coated with 500 μg/ml of Matrigel and placed in Transwell well chambers by methods previously described. The coated filters were washed thoroughly in PBS and dried immediately before use. Cells were placed in the upper part of the transwell plate and incubated with 6,6'-bieckol for 24 h at 37 o C. The cells that invaded to the lower surface of the membrane were fixed with methanol and stained with 0.5% crystal violet for 10 min. Finally, we determined invasive phenotypes by counting the cells that migrated to the lower side of the filter using microscopy at 200X.
In vitro wound migration assay
A cell migration assay was performed as previously described (32) . HT1080 cell line were seeded in 6-well plate Cells. Cells were pretreated with mitomycin C (25 μg/ml) for 30 min before an injury line was made with a 1 mm width tip on cells that were plated in culture dishes at 80% confluence, then cells being washed with PBS. The cells were allowed to migrate in serum-free medium in the presence of different concentrations of 6,6'-bieckol for 36 h. The results were observed on microscope (IX-51, Olympus, Japan).
In vitro three-dimensional (3D) culture of HT1080 cell line
The 3D culture model was established as described previously (33, 34, 18) . Briefly, HT1080 cell line (1.5 × 10 
Gelatin zymography
Gelatin zymography was used to determine expression and activities of MMP-2 and -9 in 6,6'-bieckol treated HT1080. HT1080 cell line were seeded in 24-well plates using serum-free media and pre-treated with different concentrations of 6,6'-bieckol for 1 h. Expression of MMPs was stimulated by treating with PMA (10 ng/ml) and incubation was continued for another 48 h. After incubation, conditioned media were collected and their protein contents were determined by Bradford protein determination method. Culture supernatants were resuspended in a sample buffer containing 62.5 mM Tris-HCl (pH 6.8), 10% glycerol, 2% SDS, and 0.00625% (w/v) bromophenol blue and loaded without boiling in 10% (w/v) acrylamide gel containing gelatin containing 0.1% (w/v) gelatin. After electrophoresis, the gels were washed for 1 h in 2.5% (v/v) Triton X-100 to remove SDS, and then incubated for 36 h at 37 o C in the incubation buffer (50 mM Tris-HCl (pH 7.5), 0.15 M NaCl, 10 mM CaCl2, and 1 μM ZnCl2) to allow proteolysis of the gelatin substrate. Bands corresponding to activity were visualized by negative staining using Coomassie Brilliant blue R-250 (Bio-Rad, Richmond, CA) and molecular weights were estimated by reference to prestained SDS-PAGE markers and MMP standards (Chemicon) (35) .
Western blot analysis
HT1080 cell line treated with or without different concentrations of 6,6'-bieckol and followed by stimulation with PMA were lysed in 1% Nonidet P-40 lysis buffer with phosphatase inhibitors and proteinase inhibitors. The lysates were centrifuged, and supernatants were separated by 10% SDS-polyacrylamide gel electrophoresis, and proteins electrotransferred onto PVDF membranes (Millipore, Bedford, MA), and PVDF membranes blocked with 10% skim milk in 0.2% Tween-20 in PBS and incubated with primary antibody for 1 h, washed with 0.2% Tween-20 in PBS, and then incubated with HRP-linked secondary antibody. Visualization of immunoreactive proteins was performed with DAB reagent (36) .
Statistical analysis
Data were expressed as mean ± standard error of the mean. Student's t-test was used to determine the level of significance at P ＜ 0.05.
